The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
…, R Berard, ML Shirley, K Morishita… - Annals of the …, 2015 - ard.bmj.com
Objective To describe clinical outcomes of juvenile idiopathic arthritis (JIA) in a prospective
inception cohort of children managed with contemporary treatments. Methods Children newly …
inception cohort of children managed with contemporary treatments. Methods Children newly …
Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an …
…, D McCurdy, LN Moorthy, KA Morishita… - Arthritis & …, 2016 - Wiley Online Library
Objective To uniquely classify children with microscopic polyangiitis (MPA), to describe their
demographic characteristics, presenting clinical features, and initial treatments in …
demographic characteristics, presenting clinical features, and initial treatments in …
Musculoskeletal manifestations of mucopolysaccharidoses
K Morishita, RE Petty - Rheumatology, 2011 - academic.oup.com
The mucopolysaccharidoses (MPSs) are a heterogeneous group of inherited metabolic
disorders caused by enzyme deficiencies that lead to progressive lysosomal storage of …
disorders caused by enzyme deficiencies that lead to progressive lysosomal storage of …
The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort
…, E Stringer, R Scuccimarri, K Morishita… - Annals of the …, 2016 - ard.bmj.com
Objective To describe probabilities and characteristics of disease flares in children with juvenile
idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk …
idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk …
Mortality in Wegener's granulomatosis: a bimodal pattern
…, J Maskell, D Culliford, D Jayne, K Morishita… - …, 2011 - academic.oup.com
Objective. To characterize the long-term mortality in patients with WG compared with matched
population-based controls. Methods. We used data from the General Practice Research …
population-based controls. Methods. We used data from the General Practice Research …
[PDF][PDF] Health‐related quality of life in an inception cohort of children with juvenile idiopathic arthritis: a longitudinal analysis
…, R Scuccimarri, DA Cabral, KA Morishita… - Arthritis care & …, 2018 - Wiley Online Library
Objective To describe changes in health‐related quality of life ( HRQ oL) over time in children
with juvenile idiopathic arthritis ( JIA ), relative to other outcomes, and to identify predictors …
with juvenile idiopathic arthritis ( JIA ), relative to other outcomes, and to identify predictors …
Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience
…, K Houghton, DA Cabral, K Morishita… - …, 2020 - academic.oup.com
Objective To assess long-term outcomes of children with JIA diagnosed in the biologic era.
Methods Chart review of patients prospectively enrolled in the Research in Arthritis in …
Methods Chart review of patients prospectively enrolled in the Research in Arthritis in …
Early outcomes in children with antineutrophil cytoplasmic antibody–associated vasculitis
KA Morishita, LN Moorthy… - Arthritis & …, 2017 - Wiley Online Library
Objective To characterize the early disease course in childhood‐onset antineutrophil cytoplasmic
antibody (ANCA)–associated vasculitis (AAV) and the 12‐month outcomes in children …
antibody (ANCA)–associated vasculitis (AAV) and the 12‐month outcomes in children …
Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.
O Ortiz-Alvarez, K Morishita, G Avery, J Green… - The Journal of …, 2004 - jrheum.org
OBJECTIVE: To assess the utility of the American College of Rheumatology guidelines for
monitoring methotrexate (MTX)-related toxicity in a cohort of children with juvenile idiopathic …
monitoring methotrexate (MTX)-related toxicity in a cohort of children with juvenile idiopathic …
Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis
KM Gibson, KA Morishita, P Dancey… - Arthritis & …, 2019 - Wiley Online Library
Objective Individuals with deficiency of adenosine deaminase 2 ( DADA 2), a recently recognized
autosomal recessive disease, present with various systemic vascular and inflammatory …
autosomal recessive disease, present with various systemic vascular and inflammatory …